OverviewSuggest Edit
Orthofix is a medical device company focused on musculoskeletal products and therapies. It operates Orthofix Spine and Orthofix Extremities business units. The company develops, manufactures, and distributes reconstruction and regenerative spine and extremity products that empower surgeons to meet the needs of their patients.
| Type | Public | |
| Founded | 1980 | |
| HQ | Lewisville, TX, US | Map |
| Website | orthofix.com | |
| Employee Ratings | More | |
| Overall Culture | C | More |
Recent NewsAll News
- Global $10.3 Billion Sports Medicine Technologies and Markets to 2026 Featuring Anika Therapeutics, Bioventus, DePuy Synthes, Emcyte, Medtronic, Orthofix, Smith & Nephew, and Stryker
- Medical device maker Orthofix warns that Q3 revenue will rise only in low-single digits as COVID delays procedures
- Orthofix Announces Board Chair Transition
- Orthofix Launches Nationwide Recycling Program to Improve Sustainability
Key People/Management at Orthofix
Jon Serbousek
Director, President, and Chief Executive Officer
Jill Mason
Chief Ethics and Compliance Officer
Kimberley Elting
Chief Legal and Development Officer
Doug Rice
Chief Financial Officer
Ehab Esmail
Senior Vice President of Quality, Regulatory and Clinical Affairs
Roberto Donadello
Senior Vice President, Global Operations
Orthofix Office Locations
Orthofix has offices in Lewisville, Sunnyvale, Sao Paulo, Arcueil and in 5 other locations
Lewisville, TX, US (HQ)
3451 Plano Pkwy
Sunnyvale, CA, US
501 Mercury Dr
Sao Paulo, BR
Alameda Santos, 1978 - conj 162, 16°andar - Jardim Paulista
Arcueil, FR
28 Villa Baudran 24
Paris, FR
259 Rue Saint-Honoré
Ottobrunn, DE
5 Siemensstraße
Orthofix Financials and Metrics
Orthofix Revenue
Orthofix's revenue was reported to be $406.56 m in FY, 2020
| USD | |
|---|---|
Revenue (Q1, 2021) | 105.6m |
Gross profit (Q1, 2021) | 79.7m |
Gross profit margin (Q1, 2021), % | 75.5% |
Net income (Q1, 2021) | (5.8m) |
EBIT (Q1, 2021) | (2.9m) |
Market capitalization (22-Apr-2022) | 637.8m |
Closing stock price (22-Apr-2022) | 32.3 |
Cash (31-Mar-2021) | 94.6m |
EV | 563.5m |
Orthofix's current market capitalization is $637.8 m.
Annual
Quarterly
| USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 108.7m | 111.5m | 111.7m | 109.1m | 115.9m | 113.5m | 104.8m | 73.1m | 111.0m | 105.6m |
Cost of goods sold | 24.1m | 22.8m | 24.0m | 23.7m | 25.8m | 24.9m | 23.4m | 23.2m | 26.2m | 25.9m |
Gross profit | 84.6m | 88.7m | 87.7m | 85.4m | 90.0m | 88.6m | 81.4m | 50.0m | 84.7m | 79.7m |
Gross profit Margin, % | 78% | 80% | 78% | 78% | 78% | 78% | 78% | 68% | 76% | 75% |
Annual
Quarterly
| USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash | 77.1m | 45.7m | 53.8m | 46.7m | 52.1m | 56.8m | 57.7m | 172.9m | 79.8m | 94.6m |
Accounts Receivable | 77.2m | 74.4m | 74.4m | 79.6m | 80.6m | 79.7m | 77.8m | 67.4m | 73.1m | 69.7m |
Prepaid Expenses | 31.2m | 35.6m | 34.5m | 16.4m | 21.0m | 19.6m | 21.2m | 20.7m | 18.5m | 14.4m |
Inventories | 77.7m | 81.7m | 79.9m | 79.1m | 79.1m | 81.0m | 82.7m | 82.0m | 82.9m | 84.2m |
Annual
Quarterly
| USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 5.2m | 6.2m | 4.9m | 897.0k | 350.0k | (40.1m) | 25.7m | 7.2m | 11.9m | (5.8m) |
Depreciation and Amortization | 4.4m | 8.9m | 13.7m | 5.7m | 11.9m | 18.2m | 6.3m | 13.3m | 22.3m | 7.4m |
Inventories | 1.7m | 5.3m | 6.9m | (2.5m) | (2.4m) | (5.0m) | (848.0k) | 468.0k | 246.0k | 16.0k |
Accounts Payable | (4.5m) | (3.8m) | (2.8m) | 1.9m | 1.6m | 447.0k | 28.0k | (4.8m) | (3.1m) | (1.5m) |
| USD | FY, 2017 |
|---|---|
Revenue/Employee | 505.6k |
Financial Leverage | 1.4 x |
Orthofix Revenue Breakdown
Orthofix revenue breakdown by business segment: 42.9% from Bone Growth Therapies, 22.3% from Orthofix Extremities, 20.6% from Spinal Implants and 14.2% from Biologics
Orthofix revenue breakdown by geographic segment: 78.7% from United States and 21.3% from Other
Orthofix Cybersecurity Score
Orthofix Environment, Social & Governance (ESG) Ratings
Orthofix Online and Social Media Presence
Orthofix's Trends
Orthofix Company Culture
Overall Culture
C
67/100
CEO Rating
D-
55/100
Compensation
B+
78/100
Diversity
B
72/100
Orthofix News and Updates
November 08, 2021
Global $10.3 Billion Sports Medicine Technologies and Markets to 2026 Featuring Anika Therapeutics, Bioventus, DePuy Synthes, Emcyte, Medtronic, Orthofix, Smith & Nephew, and Stryker
Dublin, Nov. 08, 2021 (GLOBE NEWSWIRE) -- The "Sports Medicine: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering.
September 29, 2021
Medical device maker Orthofix warns that Q3 revenue will rise only in low-single digits as COVID delays procedures
Orthofix Medical Inc. said Wednesday it expects third-quarter revenue growth to come in at a low single-digit increase over the year-earlier period, hurt by the high volume of elective procedures that have been deferred or rescheduled in the U.S. and overseas because of the recent surge in cases of…
April 07, 2021
Orthofix Announces Board Chair Transition
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced that Ron Matricaria, Chairman of the Orthofix Board of Directors since 2014, has decided not to stand for re-election at the Company’s 2021 Annual Meeting in order to focus on ot…
March 10, 2021
Orthofix Launches Nationwide Recycling Program to Improve Sustainability
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced the launch of a nationwide recycling program to improve sustainability efforts. Orthofix is the first and only company in the U.S. to offer a free recycling program so patients c…
February 11, 2021
Orthofix Announces US and European Full Market Launch of FITBONE Limb-Lengthening System
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced the U.S. and European full market launch of the FITBONE® intramedullary lengthening system for limb lengthening and deformity correction of the femur and tibia bones
February 11, 2021
Orthofix Schedules Fourth Quarter and Full Year Earnings Release and Conference Call for February 26, 2021
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced that it plans to release financial results for the fourth quarter and full year 2020 before market open on Friday, February 26, 2021. Jon Serbousek, President and Chief Executive …
Orthofix Blogs
May 04, 2022
FDA Approves AccelStim Bone Healing Therapy Device and Expands Orthofix’s Portfolio of Bone Growth Stimulation Solutions
LEWISVILLE, Texas–(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the U.S. Food and Drug Administration (FDA) pre-market approval for the AccelStim™ bone healing therapy Class III device. The AccelStim device p…
March 21, 2022
Orthofix Teams Up with Olympian and Spine Patient Laura Wilkinson
Your browser does not support the video tag. Orthofix is a Proud Sponsor of Olympian Laura Wilkinson “In order to do things no one has ever done, you have to be willing to do things no one else is willing to do.” Laura Wilkinson made history at the 2000 Olympics when she became the first…
The post O…
March 20, 2022
Orthofix Supports Medical and Relief Efforts in Ukraine
Orthofix is supporting the humanitarian efforts underway in Ukraine and neighboring countries through a $25,000 donation to the International Medical Corps. Inside Ukraine and the surrounding region, the International Medical Corps’ teams are responding to this crisis by expanding access to medical …
May 05, 2021
Olympian and Orthofix Patient Laura Wilkinson Goes for the Gold Once Again
Your browser does not support the video tag. Orthofix is a proud sponsor of Olympian Laura Wilkinson for the Olympic Games, now scheduled for summer 2021 “In order to do things no one has ever done, you have to be willing to do things no one else is willing to do.” Laura Wilkinson made history…
October 07, 2020
Orthofix Launches O-GENESIS Graft Delivery System and New Hydrated, Ready-to-Use AlloQuent Structural Allograft Q-PACK
Orthofix Launches O-GENESIS Graft Delivery System and New Hydrated, Ready-to-Use AlloQuent Structural Allograft Q-PACK
Content Import
Wed, 10/07/2020 - 07:00
Orthofix Launches O-GENESIS Graft Delivery System and New Hydrated, Ready-to-Use AlloQuent Structural Allograft Q-PACK
…
October 06, 2020
Orthofix Announces Presentation of Clinical and Scientific Abstracts During the North American Spine Society Annual Meeting
Orthofix Announces Presentation of Clinical and Scientific Abstracts During the North American Spine Society Annual Meeting
Content Import
Tue, 10/06/2020 - 07:01
Orthofix Announces Presentation of Clinical and Scientific Abstracts During the North American Spine Society Annual Meeting
…
Orthofix Frequently Asked Questions
When was Orthofix founded?
Orthofix was founded in 1980.
Who are Orthofix key executives?
Orthofix's key executives are Jon Serbousek, Jill Mason and Kimberley Elting.
How many employees does Orthofix have?
Orthofix has 1,055 employees.
What is Orthofix revenue?
Latest Orthofix annual revenue is $406.6 m.
What is Orthofix revenue per employee?
Latest Orthofix revenue per employee is $385.4 k.
Who are Orthofix competitors?
Competitors of Orthofix include Medtronic, Bioventus and Mammotome.
Where is Orthofix headquarters?
Orthofix headquarters is located at 3451 Plano Pkwy, Lewisville.
Where are Orthofix offices?
Orthofix has offices in Lewisville, Sunnyvale, Sao Paulo, Arcueil and in 5 other locations.
How many offices does Orthofix have?
Orthofix has 9 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies